About this trial
The overall goal of this study is to assess the efficacy of the care.coach Avatar™ in improving anxiety and quality of life for patients undergoing outpatient transplant. After care.coach Avatar™ content and scheduling ("digital intervention" or "program") has been optimized for outpatient allogeneic hematopoietic stem cell transplantation (HCT), a randomized controlled trial (RCT) will be conducted of the digital versus usual supportive care program for outpatient HCT recipients. Potential improvements in anxiety and quality of life will be evaluated, with the intent of increasing comfortability with outpatient transplant and expanding the population of eligible patients willing to receive their transplants in an outpatient setting.
Eligibility criteria
Qualifiers
Age 18+
Seen for outpatient RIC HCT (prior to D0, generally D-6).
Disqualifiers
Deemed by clinical staff or research assistant (RA) to be unable to converse with an avatar, due to: severe, uncorrectable hearing or vision impairment; severe speech impairment that precludes understanding by staff (or by the avatar).
Not fluent in English.
Trial design
Treatments tested in this trial
- care.coach Avatar™
Treatment groups
Sponsors and collaborators
Victor Wang
Lead sponsor
Friendi.fi Corporation
Sponsor institution
Dana-Farber Cancer Institute
Collaborator
care.coach corporation
Collaborator